Lysogene

Developer of gene therapies for neurodegenerative lysosomal storage disorders

placeNeuilly Sur Seine, Ile De France, France calendar_todayFounded 2009 groups22 employees language lysogene.com

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 55 times.

YearFilings
20212
20221
20233

Investor mix

5 investors on record; lead investors include Sofinnova Partners; 1 has since exited.

Investor typeCountShare
Venture capital240%
Bank & private debt120%
Other / undisclosed240%
Coming soon